Clin Mol Hepatol.
2015 Mar;21(1):1-6. 10.3350/cmh.2015.21.1.1.
Personalized treatment of hepatitis B
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA. aslok@umich.edu
- KMID: 2155284
- DOI: http://doi.org/10.3350/cmh.2015.21.1.1
Abstract
- There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be applied based on prediction of the individual patient's risk of cirrhosis and hepatocellular carcinoma to guide the frequency and intensity of monitoring and urgency of treatment. It can also be applied to decisions regarding when to start treatment, which drug to use, and when to stop based on the individual patient's disease characteristics, preference, comorbidities and other mitigating circumstances.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
- Prevention of Viral Hepatitis and Vaccination
- Treatment of chronic hepatitis C
- A Study on Periphral T Cell Subsets in Asymptomatic HBsAg Carriers and Children with Chronic Hepatitis B and Hepatitis B vaccine Inoculated Infants
- A study on the relationship between HBeAg and hepatitis B virus DNAamong healthy HBsAg carries
